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to identify regions associated with increased susceptibility to generalized
OA.
Methods: A total of 2728 subjects from 1145 pedigrees were enrolled at
seven academic sites in the US and UK. A qualifying pedigree consisted
of at least two affected sibs with clinical hand OA who were of self-
reported Caucasian ethnicity. Individuals were subsequently classiﬁed as
having hand, hip, knee and/or spine OA based on prespeciﬁed radio-
graphic criteria (see OA Cart 2006;15:120−7 for case deﬁnitions). A total
of 2148 subjects from 880 families were genotyped using the deCODE
4cM Genome Wide Scan marker set (deCODE Genetics, Reykjavik,
Iceland), that consists of 1115 short sequence repeat (SSR) microsatellite
markers distributed at an average density of 1 SSR marker per 4 cM over
all 22 autosomes and the two sex chromosomes. For the high-density
association (HDA) analysis, 786 siblings with multiple-joint OA from 533
nuclear families (330 families with one affected sibling and 203 families
with more than one affected sibling) and 511 unaffected controls from the
Genetics of Osteoarthritis (GO) study, a genetic association study using
identical phenotypic procedures and deﬁnitions, were selected for SNP
typing. The genome wide linkage scan was analyzed using MERLIN; for
the HDA analysis, tests for genotypic and allelic association were applied
to each marker.
Results: Overall, LOD scores >2 were observed for six chromosome
and phenotype pairs (ﬁve chromosomes [2, 10, 18, 20, and X] and
three phenotypes [hand CMC, hand PIP, and knee OA]) (see Table). The
highest LOD score was 3.01 on chromosome 2 at 123.0 cM for hand PIP.
The next highest LOD score was 2.41 on chromosome 18 at 66.6 cM,
region 18q21, for knee OA. Owing to the comparative lack of information
regarding OA susceptibility for the chromosome 18 region, a HDA analysis
was conducted on 18q21. Of the 1797 SNPs tested, 151, 162, 134,
133 and 135 showed evidence of association (P< 0.05 for the allelic or
genotypic test) with hand OA, hand DIP OA, hand PIP OA, knee OA, and
spine OA, respectively; 28 of these SNPs showed consistent association
(P< 0.05) with all ﬁve OA phenotypes. Two SNPs within gene APM-1
(Adipose most abundant gene transcript 1) showed strong association
(P< 0.01) with hand and knee OA, while strong associations were also
observed within gene WDR7 (WD repeat domain 7 [alias TRAG, TGF-B
resistance associated gene]) for hand OA (P< 0.01), genes DCC (Deleted
in colorectal cancer [aliases CRC18, CRCR1]) and TXNL1 (thioredoxin-
like 1 [alias TRP32]) (P< 0.001) for knee OA, and within gene LOC390858
(P< 0.001) for spine OA.
Conclusions: These data extend results of previous genome wide link-
age scans that have identiﬁed chromosome 2 and implicate genes in a
new area of chromosome 18 as being associated with generalized OA.
Chromosome Regions with LOD Scores >2.0 on Genome Wide Linkage Scan, The GOGO Study
Chromosome Location (cM) One LOD drop interval (cM) OA Phenotype LOD Score
2 158.0 148.0–187.0 Hand CMC 2.16
2 123.0 117.0–129.0 Hand PIP 3.01
10 Telomere 0.0−9.2 Hand CMC 2.04
18 66.6 60.1−86.1 Knee OA 2.41
20 40.0 33.0−46.0 Hand CMC 2.17
X 153.2 132.2–163.2 Hand PIP 2.13
X 158.7 149.2–161.2 Hand CMC 2.19
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Purpose: There continues to be a need for reliable markers to predict
which osteoarthritis (OA) patients will experience disease progression.
Previous studies have suggested that inﬂammation may be important in
the pathogenesis and progression of OA. We performed a study in sub-
jects with knee OA to investigate selected candidate gene polymorphisms
for associations with radiographic severity.
Methods: One hundred thirty OA patients with knee OA from two
separate study center databases (New York Hospital for Joint Diseases;
NYUHJD, N=80 and Duke University Medical Center, N=50) met inclu-
sion criteria in this cross-sectional retrospective analysis. Caucasians of
either sex, free of chronic disease, with a radiographic diagnosis of knee
OA were genotyped for single nucleotide polymorphisms (SNPs). These
subjects were divided into two groups: one having index knee Kellgren-
Lawrence (KL) scores of one or two, and the other, KL scores of three or
four. A subset (NYUHJD) with available data (N=36) was separated by
joint space width (JSW) either above or below the median. We performed
statistical analysis using Chi square and Fisher’s exact test, and logistic
regression, adjusting for age, gender and BMI to evaluate associations
of radiographic severity with individual SNPs and with haplotypes.
Results: After adjustment for age, gender, and BMI, individual IL1
receptor antagonist (IL1RN) SNPs were strongly associated with KL
radiographic severity and joint space width (JSW; Table 1). The KL results
were conﬁrmed separately in NYUHJD and Duke cohorts. Also, carriage
of either one or two copies of a haplotype consisting of (ACT): IL1RN
rs9005, IL1RN rs419598, IL1RN rs315952 (haplotype frequency in this
OA study 25−32%) was associated with a substantially decreased risk of
radiographic severity (OR 0.16; 95%CI 0.06−0.40), and with JSW above
the median (OR 25.4; 95% CI 1.59–404.2) compared to the remaining
68−75% of the OA population.
Table 1: Association of SNPs with radiographic severity
Genotypes KL score> 2 (N=130) JSW<median (N=36)
SNP genotype freq p OR (95%CI) p OR (95%CI)
IL1RN rs9005 GG 55% <0.0001 8.59 (3.64−20.28) 0.007 14.5 (2.05–103.1)
AA/AG 45% 1.0 1.0
IL1RN rs419598 TT 65% <0.0001 5.45 (2.27−13.09) 0.016 28.7 (1.86–445.0)
CC/CT 35% 1.0 1.0
IL1RN rs315952 CC/CT 47% 0.027 2.79 (1.33−5.86) NS NS
TT 52% 1.0
Conclusions: IL1RN SNPs are associated with radiographic severity in
OA, and may predict the potential for radiographic severity and progres-
sion. These genetic markers may be useful for the medical management
of OA, and also as a tool to enrich for subjects who progress radiograph-
ically in clinical trials of DMOADs.
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Purpose: Lumbar degenerative disc disease (LDD) is a major cause
of back pain which is a considerable public health problem in Western
countries. Back pain is a common cause of work absenteeism and the
prevalence is increasing. LDD is known to be inﬂuenced by genetic
factors, with estimated heritability >70%. Little is known, however, of the
pathogenic processes underlying the development of degenerate discs. A
number of genetic loci, including polymorphisms within COL 9, VDR and
certain inﬂammation-related genes, have been shown to be associated
with LDD. LDD has much in common with osteoarthritis (OA) at the
knee: the pathophysiological changes are similar in cartilage and disc,
the conditions have genes in common and progression at the knee is
predicted by LDD. In the present study, we sought to identify novel genetic
determinants of LDD by examining single nucleotide polymorphisms
(SNPs) which had previously been found associated with knee OA.
Methods: Two population based cohorts were used in this study, TwinsUK
and the Chingford Study. All participants gave written consent and ethics
committee approval was obtained. Female participants in the Chingford
study (n = 670) underwent plain radiography with standard lateral lumbar
spine ﬁlm. LDD was scored using a 4-point scale for disc space narrow-
ing (DSN) and anterior osteophytes (AO). Female twins (n = 291) from
the TwinsUK cohort were selected who had previously undergone T2-
weighted sagittal MRI scanning of the lumbar spine. The scans had been
coded for degenerative change using a 4-point scale at each of: DSN,
disc signal intensity, disc bulge and AO. A cumulative overall score for
LDD was derived by summing the 4-point scale for the 4 features over
all the lumbar disc levels. A panel of 28 SNPs derived from a genome
wide scan (GWS) of knee OA was used. These were tested initially in
women from the Chingford study, and the top SNP was carried through to
a replication group from TwinsUK. Work was carried out using software
packages R and Helixtree.
Results: After adjustment for age and body mass index, only one SNP
of the 28 identiﬁed in the knee OA GWS was associated with both
DSN (p< 0.004) and AO (p< 0.007) in the Chingford Study participants.
Individuals carrying one or two copies of the G allele (minor allele
frequency = 25%) had an 11% higher AO grade and 18% higher DSN
grade. This SNP was subsequently found to be associated with the
overall score for LDD in the TwinsUK participants (p< 0.04). In particular,
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carrying one or two copies of the G allele was associated with 13% higher
grade – corresponding to lower disc signal intensity – than that of AA
homozygotes (adjustment as before, p< 0.02). The SNP detected maps
to chromosome 15q22 and a gene of as yet unknown function. Of interest,
this gene has been shown in human tissue microarray experiments to be
up-regulated in bone from non-healing versus normal healing fracture,
pointing to a role in bone formation and/or remodeling. Furthermore,
we went on to test this SNP for association with spine bone mineral
density (BMD). In the TwinsUK cohort the genotype was signiﬁcantly
associated with spine BMD (after adjustment, p< 0.002). A similar trend
was observed among women from the Chingford cohort (p< 0.06) but
only among women who did not report back pain.
Conclusions: These results from two independent population based
cohorts of women point to a novel genetic variant involved in the sus-
ceptibility to LDD. It is possible that this variant acts to promote LDD
through altering local bone metabolism.
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Purpose: The Wnt-beta-catenin signaling pathway is a powerful stim-
ulator of chondrocyte matrix catabolic action and may have a role in
excessive remodeling and degradation of cartilage matrix in osteoarthritis
(OA). The ANP32A gene encodes a tumor suppressor molecule – pp32 –
involved in ERK signaling and shown to inhibit canonical Wnt signaling
via its interaction with Axin1. Wnt5a is a mediator of non-canonical Wnt
signaling, involved in inﬂammation, angiogenesis and down-regulation
of the canonical Wnt pathway. We tested whether variation at genes
encoding these two Wnt signaling molecules was associated with OA
of the hip or the knee in women in 2479 women from the UK and
1987 women from the Netherlands.
Methods: Two SNPs in the WNT5A gene and 8 SNPs in the ANP32A
gene were genotyped in 435 controls, 643 knee OA cases and 571 hip
OA female cases from Nottingham (UK). Results were replicated in a
population based cohort, the Chingford study of 830 women. The top
SNP from the ANP32A gene was also replicated in women from the
Rotterdam study (131 total hip replacement cases and 1856 controls).
Results: Five SNPs in the ANP32A gene and both of the WNT5A
SNPS were signiﬁcantly associated with hip OA in the Nottingham cases
(p< 0.009 and p< 0.002 best p-values respectively) but not knee OA.
The Wnt5A SNPs were not associated with knee OA in the Chingford
cohort but had p-values of p< 0.02 and p< 0.08 for hip OA. Combining
Chingford and Nottingham data resulted in a Mantel-Haenszel odds ratio
of 1.49 (95% CI 1.18−1.88; p< 8×10−4) for the minor allele of rs648872
and an ORMH =0.79 (95% CI 0.66−0.94; p< 0.009) for the minor allele of
rs1047898. Of the ﬁve ANP32A SNPs signiﬁcant in the Nottingham hip
OA cases, two were also associated with hip OA (rs7164503 p< 0.016
and rs1551343 p< 0.049) and rs7164503 also with knee OA (p< 0.048) in
the Chingford study. A meta-analysis of hip OA incorporating data of the
Rotterdam cohort yielded an ORMH =0.69 (95% CI 0.54−0.90; p< 0.0033)
for the minor allele of rs7164503. The ANP32A transcript was found to
be abundantly expressed in articular cartilage from OA patients and the
minor allele at rs7164503 was associated with signiﬁcantly lower cis-
acting allelic expression levels of the ANP32A transcript in lymphoblast
cell lines.
Conclusions: Our results demonstrate two novel gene loci are associ-
ated with OA and provide further evidence that Wnt-beta-catenin signaling
molecules are involved in the pathogenesis of cartilage related diseases.
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